DSP Healthcare Fund
- NAV as on 25 Sep 2026
- ₹45.74-0.17%1 day
- Return since launch
- 21.4%
- 52-week range
- ₹35.84 — ₹46.15
- AUM
- ₹3,835 Cr
DSP Healthcare Fund is a Sectoral-Pharma equity fund from DSP Mutual Fund with ₹3,835 Cr under management, launched in 2018. Over three years it has returned 15.7% a year, against 21.1% for its category. The expense ratio is 2.04% and the SEBI riskometer reading is Very High.
Performance
DSP Healthcare Fund NAV and returns
Growth of the fund against its category average over the period you pick.
Over 1Y this fund returned +19.4% against +19.5% for its category.
Performance
Returns
How the fund has done against its category and its benchmark.
| Period | Fund | vs category | Category | Benchmark |
|---|---|---|---|---|
| 1Y | 28.3% | +7.4 pts | 20.9% | 26.4% |
| 2Y | 14.9% | −1.9 pts | 16.8% | 15.2% |
| 3Y | 15.7% | −5.4 pts | 21.1% | 15.8% |
| 5Y | 18.8% | +4.5 pts | 14.3% | 18.0% |
| 7Y | 19.7% | +0.5 pts | 19.2% | 18.1% |
| Period | Fund | vs category | Category | Benchmark |
|---|---|---|---|---|
| 1M | -0.6% | −0.8 pts | 0.2% | -0.3% |
| 3M | 6.7% | +0.5 pts | 6.2% | 6.0% |
| 6M | 26.0% | +3.9 pts | 22.1% | 20.9% |
| 1Y | 19.4% | −1.5 pts | 20.9% | 19.5% |
| 2Y | 6.1% | −2.1 pts | 8.2% | 6.5% |
| 3Y | 21.4% | +0.3 pts | 21.1% | 20.1% |
| 5Y | 14.5% | +0.2 pts | 14.3% | 13.4% |
| 7Y | 24.1% | +1.7 pts | 22.4% | 21.3% |
Since launch (12 Nov 2018): 21.4%
Calendar-year returns
Category averageShow as a table
| Period | Fund | vs category | Category |
|---|---|---|---|
| 2025 | -5.8% | −3.8 pts | -2.0% |
| 2024 | 40.3% | −0.6 pts | 40.9% |
| 2023 | 35.0% | −1.3 pts | 36.2% |
| 2022 | -7.8% | +0.5 pts | -8.3% |
| 2021 | 23.3% | +1.6 pts | 21.7% |
| 2020 | 76.9% | +8.1 pts | 68.8% |
Returns over one year are annualised. Shorter periods are absolute.
Costs & terms
Costs and terms
What the fund charges each year, and the rules around putting money in and taking it out.
Costs
2.05%
Expense ratio as on 25 Sep 2026
Charged yearly and already deducted from the NAV.
- Base expense
- 1.64%
- Brokerage
- 0.04%
- Transaction charges
- 0.00%
- Statutory levies
- 0.37%
- Exit load
- Exit load of 0.50% if redeemed within 1 month.
- Lock-in
- None
Terms
- Min SIP
- ₹3,000
- Min lumpsum
- ₹5,000
- Plan
- GROWTH
- Fund type
- OPEN-ENDED
- Benchmark
- BSE Healthcare TRI
- Short-term capital gains
- Returns taxed at 20% if you redeem before 1 year
- Long-term capital gains
- After 1 year, returns above ₹1.25 lakh in a financial year are taxed at 12.5%
Risk
Risk
What the riskometer means for this fund, and how its ratios sit against the category.
Your principal is treated as being at very high risk — typically small cap, sectoral and thematic equity schemes.
| Ratio | Fund | Category avg | Read as |
|---|---|---|---|
| Alpha | 0.64 | 0.74 | Return earned above what the benchmark alone would have given. Higher is better. |
| Beta | 0.84 | 0.93 | How hard the fund moves when the market moves. Under 1 is steadier than the market. |
| Sharpe | 0.99 | 1.05 | Return earned for each unit of total risk taken. Higher is better. |
| Sortino | 1.61 | 1.63 | Return earned for each unit of downside risk. Higher is better. |
| Std. deviation | 14.89 | 15.68 | How widely monthly returns have varied around their own average. Lower is steadier. |
| Average of 5 category peers | |||
Portfolio
DSP Healthcare Fund portfolio
Portfolio as of 31 Aug 2026
Asset allocation
- Equity97.1%
- Other2.9%
Market cap split
- Large29.7%
- Mid23.9%
- Small46.3%
- P/E
- 37.51
- P/B
- 4.48
Top holdings
| Holding | Sector | Weight | Value | 3M chg | 6M chg | 1Y chg |
|---|---|---|---|---|---|---|
| Ipca Laboratories Ltd. | Healthcare | 8.74% | ₹335 Cr | +7.81% | +8.55% | +7.56% |
| Sun Pharmaceutical Industries Ltd. | Healthcare | 7.95% | ₹305 Cr | +8.35% | +8.79% | +7.88% |
| Sai Life Sciences Ltd. | Healthcare | 7.45% | ₹286 Cr | +6.86% | +5.90% | +4.52% |
| Cipla Ltd. | Healthcare | 7.35% | ₹282 Cr | +7.68% | +8.06% | +9.16% |
| Apollo Hospitals Enterprise Ltd. | Healthcare | 6.47% | ₹248 Cr | +4.81% | +5.02% | +4.77% |
| Gland Pharma Ltd. | Healthcare | 5.98% | ₹229 Cr | +6.26% | +5.53% | +5.55% |
| Globus Medical Inc | Healthcare | 5.44% | ₹209 Cr | +6.34% | +7.69% | +4.66% |
| Divi's Laboratories Ltd. | Healthcare | 4.15% | ₹159 Cr | — | — | — |
| Alkem Laboratories Ltd. | Healthcare | 4.08% | ₹157 Cr | +0.62% | +0.69% | +0.64% |
| Cohance Lifesciences Ltd. | Healthcare | 3.81% | ₹146 Cr | +4.15% | +3.04% | +7.38% |
| Manipal Health Enterprises Ltd. | Healthcare | 3.70% | ₹142 Cr | — | — | — |
| Pfizer Ltd. | Healthcare | 3.22% | ₹123 Cr | +2.79% | +3.35% | +3.33% |
| Alembic Pharmaceuticals Ltd. | Healthcare | 3.14% | ₹120 Cr | +3.21% | +3.35% | +4.31% |
| Others | Others | 2.88% | ₹110 Cr | -0.30% | -0.14% | -0.08% |
| Kovai Medical Center & Hospital Ltd. | Healthcare | 2.80% | ₹107 Cr | +2.68% | +2.88% | +3.37% |
| Concord Biotech Ltd. | Healthcare | 2.77% | ₹106 Cr | +1.58% | +2.00% | +2.65% |
| Vijaya Diagnostic Centre Ltd. | Healthcare | 2.44% | ₹93.49 Cr | +3.70% | +3.10% | +3.03% |
| Procter & Gamble Health Ltd. | Healthcare | 2.40% | ₹91.88 Cr | +2.92% | +2.57% | +3.27% |
| company:14273 | Healthcare | 2.11% | ₹81.07 Cr | — | — | +0.75% |
| Indoco Remedies Ltd. | Healthcare | 2.06% | ₹78.98 Cr | +2.06% | +2.16% | +2.77% |
| Intuitive Surgical Inc. (USA) | Healthcare | 1.76% | ₹67.51 Cr | +2.30% | +2.83% | +2.51% |
| Unichem Laboratories Ltd. | Healthcare | 1.64% | ₹62.82 Cr | +0.90% | +0.97% | +1.38% |
| Syngene International Ltd. | Healthcare | 1.31% | ₹50.08 Cr | — | — | — |
| Nephrocare Health Services Ltd. | Healthcare | 1.13% | ₹43.37 Cr | +1.15% | +1.24% | — |
| ICICI Lombard General Insurance Company Ltd. | Insurance | 0.99% | ₹37.83 Cr | +1.31% | +1.51% | +1.43% |
| Global X Genomics & Biotechnology ETF | Unclassified | 0.98% | ₹37.66 Cr | +0.88% | +0.88% | +0.64% |
| Aarti Drugs Ltd. | Healthcare | 0.91% | ₹35.08 Cr | +0.98% | +1.03% | +1.29% |
| Abbott Laboratories | Healthcare | 0.87% | ₹33.29 Cr | +0.78% | +1.10% | +1.19% |
| Eris Lifesciences Ltd. | Healthcare | 0.76% | ₹29.30 Cr | — | — | — |
| Jupiter Life Line Hospitals Ltd. | Healthcare | 0.40% | ₹15.27 Cr | +0.38% | +0.39% | +0.43% |
| Grail Inc | Healthcare | 0.17% | ₹6.62 Cr | +0.18% | +0.14% | +0.08% |
| Laxmi Dental Ltd. | Healthcare | 0.14% | ₹5.48 Cr | +0.20% | +0.18% | +0.31% |
Sectors
Instruments
Recent changes
| Holding | From | To | Weight |
|---|---|---|---|
| company:14273 | 0.00% | 2.11% | +2.11% |
| Divi's Laboratories Ltd. | 2.34% | 4.15% | +1.81% |
| Others | 0.53% | -0.89% | -1.42% |
| Vijaya Diagnostic Centre Ltd. | 3.47% | 2.44% | -1.03% |
| Concord Biotech Ltd. | 1.95% | 2.77% | +0.82% |
| Cipla Ltd. | 8.13% | 7.35% | -0.78% |
| Manipal Health Enterprises Ltd. | 3.02% | 3.70% | +0.68% |
| Apollo Hospitals Enterprise Ltd. | 5.81% | 6.47% | +0.66% |
| Alkem Laboratories Ltd. | 4.66% | 4.08% | -0.58% |
| Ipca Laboratories Ltd. | 8.17% | 8.74% | +0.57% |
| Procter & Gamble Health Ltd. | 2.90% | 2.40% | -0.50% |
| Pfizer Ltd. | 2.73% | 3.22% | +0.49% |
| Sun Pharmaceutical Industries Ltd. | 8.42% | 7.95% | -0.47% |
| Gland Pharma Ltd. | 6.35% | 5.98% | -0.37% |
| Sai Life Sciences Ltd. | 7.10% | 7.45% | +0.35% |
| Globus Medical Inc | 5.57% | 5.44% | -0.13% |
| Global X Genomics & Biotechnology ETF | 0.87% | 0.98% | +0.11% |
| Indoco Remedies Ltd. | 1.96% | 2.06% | +0.10% |
| ICICI Lombard General Insurance Company Ltd. | 1.08% | 0.99% | -0.09% |
| Aarti Drugs Ltd. | 0.99% | 0.91% | -0.08% |
| Eris Lifesciences Ltd. | 0.84% | 0.76% | -0.08% |
| Jupiter Life Line Hospitals Ltd. | 0.47% | 0.40% | -0.07% |
| Cohance Lifesciences Ltd. | 3.75% | 3.81% | +0.06% |
| Nephrocare Health Services Ltd. | 1.19% | 1.13% | -0.06% |
| Kovai Medical Center & Hospital Ltd. | 2.74% | 2.80% | +0.06% |
| Unichem Laboratories Ltd. | 1.59% | 1.64% | +0.05% |
| Alembic Pharmaceuticals Ltd. | 3.17% | 3.14% | -0.03% |
| Intuitive Surgical Inc. (USA) | 1.74% | 1.76% | +0.02% |
| Syngene International Ltd. | 1.33% | 1.31% | -0.02% |
| Laxmi Dental Ltd. | 0.16% | 0.14% | -0.02% |
| Abbott Laboratories | 0.88% | 0.87% | -0.01% |
| Grail Inc | 0.16% | 0.17% | +0.01% |
Compare
Similar funds
The rest of the category, so this fund’s numbers have something to sit against.
| Fund | AUM | Expense | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|
| Category average | ₹3,579 Cr | 2.19% | 27.3% | 17.7% | 20.1% |
 ICICI Prudential Healthcare Fund | ₹6,996 Cr | 2.07% | 14.5% | 14.2% | 19.4% |
 SBI Healthcare Opportunities Fund | ₹5,796 Cr | 1.99% | 33.1% | 19.9% | 22.2% |
 Mirae Asset Healthcare Fund | ₹3,555 Cr | 2.03% | 29.9% | 18.4% | 19.7% |
 UTI Healthcare Fund | ₹1,444 Cr | 2.21% | 30.4% | 19.1% | 21.1% |
 LIC MF Healthcare Fund | ₹103 Cr | 2.67% | 28.7% | 16.9% | 17.9% |
About
About this fund
The scheme’s own words, its benchmark and the people running it.
Investment objective
The scheme seeks to generate consistent returns by predominantly investing in equity and equity related securities of pharmaceutical and healthcare companies.
Fund managers
- Chirag DagliMr. Dagli has done B. COM and Chartered Accountant.Prior to joining DSP Mutual Fund, he has worked with HDFC AMC, Aviva India Life Insurance Company Ltd., ICICI Securities Ltd., Pioneer Invest Corp, Deutsche Equities, Citigroup Global Markets.
Tools
Return calculator
What ₹10,000 a month in this fund would have grown to over each period, based on its past returns.
| Over the past | Total investment | Would’ve become | Growth | Returns |
|---|---|---|---|---|
| 6 months26.01% absolute | ₹60,000 | ₹75,606 | 26.01% | |
| 1 year19.40% annualised | ₹1,20,000 | ₹1,33,389 | 11.16% | |
| 3 years21.44% annualised | ₹3,60,000 | ₹5,08,052 | 41.13% | |
| 5 years14.53% annualised | ₹6,00,000 | ₹8,85,050 | 47.51% |
Returns for 1 year and longer are annualised (CAGR); 6-month figures are absolute. Past returns are not a forecast.
How this is calculated
Each monthly instalment grows at the fund’s annualised return ÷ 12 per month until the end of the period, the same formula as our SIP calculator.
The amount compounds once a year at the fund’s CAGR for that period, the same formula as our lumpsum calculator.
Questions
Frequently asked questions
The things people ask about this scheme.